Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AIM ImmunoTech (AIM) Change in Cash (2018 - 2025)

Historic Change in Cash for ImmunoTech (AIM) over the last 11 years, with Q3 2025 value amounting to $1.9 million.

  • ImmunoTech's Change in Cash rose 17089.81% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year increase of 10997.98%. This contributed to the annual value of -$3.7 million for FY2024, which is 8270.57% up from last year.
  • ImmunoTech's Change in Cash amounted to $1.9 million in Q3 2025, which was up 17089.81% from -$422000.0 recorded in Q2 2025.
  • In the past 5 years, ImmunoTech's Change in Cash registered a high of $1.9 million during Q3 2025, and its lowest value of -$9.8 million during Q4 2023.
  • Its 3-year average for Change in Cash is -$2.2 million, with a median of -$2.1 million in 2024.
  • Over the last 5 years, ImmunoTech's Change in Cash had its largest YoY gain of 17089.81% in 2025, and its largest YoY loss of 26293.44% in 2025.
  • Over the past 3 years, ImmunoTech's Change in Cash (Quarter) stood at -$9.8 million in 2023, then soared by 108.0% to $786000.0 in 2024, then soared by 138.04% to $1.9 million in 2025.
  • Its Change in Cash stands at $1.9 million for Q3 2025, versus -$422000.0 for Q2 2025 and -$803000.0 for Q1 2025.